Overview

A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Status:
Completed

Trial end date:
2019-11-28

Target enrollment:

Participant gender:

Summary

This trial is designed to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic of KMRC011 injection in healthy adult volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Intron Biotechnology, Inc.